1-10 of 10
Mark E. Dudley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Drew C. Deniger, Mei Li M. Kwong, Anna Pasetto, Mark E. Dudley, John R. Wunderlich, Michelle M. Langhan, Chyi-Chia Richard Lee, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 351–362.
https://doi.org/10.1158/1078-0432.CCR-16-0906
Published: 15 January 2017
View article titled, A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
Open the PDF for A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma in another window
Journal Articles

Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma

Ling Zhang, Richard A. Morgan, Joal D. Beane, Zhili Zheng, Mark E. Dudley, Sadik H. Kassim, Azam V. Nahvi, Lien T. Ngo, Richard M. Sherry, Giao Q. Phan, Marybeth S. Hughes, Udai S. Kammula, Steven A. Feldman, Mary Ann Toomey, Sid P. Kerkar, Nicholas P. Restifo, James C. Yang, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2278–2288.
https://doi.org/10.1158/1078-0432.CCR-14-2085
Published: 14 May 2015
View article titled, Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
Open the PDF for Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James C. Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi-Chia R. Lee, Yong F. Li, Mona El-Gamil, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1019–1027.
https://doi.org/10.1158/1078-0432.CCR-14-2708
Published: 01 March 2015
View article titled, A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Open the PDF for A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response in another window
Includes: Supplementary data
Journal Articles

Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (3): 534–543.
https://doi.org/10.1158/1078-0432.CCR-14-2208
Published: 01 February 2015
View article titled, Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans
Open the PDF for Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans in another window
Includes: Supplementary data
Journal Articles

Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions

Yong-Chen Lu, Xin Yao, Jessica S. Crystal, Yong F. Li, Mona El-Gamil, Colin Gross, Lindy Davis, Mark E. Dudley, James C. Yang, Yardena Samuels, Steven A. Rosenberg, Paul F. Robbins
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3401–3410.
https://doi.org/10.1158/1078-0432.CCR-14-0433
Published: 30 June 2014
View article titled, Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Open the PDF for Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions in another window
Includes: Supplementary data
Journal Articles

Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma

Alena Gros, Simon Turcotte, John R. Wunderlich, Mojgan Ahmadzadeh, Mark E. Dudley, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5212–5223.
https://doi.org/10.1158/1078-0432.CCR-12-1108
Published: 30 September 2012
View article titled, Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma
Open the PDF for Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma in another window
Includes: Supplementary data
Journal Articles

Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression

Maria R. Parkhurst, John P. Riley, Mark E. Dudley, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (19): 6287–6297.
https://doi.org/10.1158/1078-0432.CCR-11-1347
Published: 02 October 2011
View article titled, Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
Open the PDF for Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression in another window
Includes: Supplementary data
Journal Articles

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurencot, Seth M. Steinberg, Donald E. White, Mark E. Dudley
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4550–4557.
https://doi.org/10.1158/1078-0432.CCR-11-0116
Published: 05 July 2011
View article titled, Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Open the PDF for Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Mark E. Dudley, Colin A. Gross, Michelle M. Langhan, Marcos R. Garcia, Richard M. Sherry, James C. Yang, Giao Q. Phan, Udai S. Kammula, Marybeth S. Hughes, Deborah E. Citrin, Nicholas P. Restifo, John R. Wunderlich, Peter A. Prieto, Jenny J. Hong, Russell C. Langan, Daniel A. Zlott, Kathleen E. Morton, Donald E. White, Carolyn M. Laurencot, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (24): 6122–6131.
https://doi.org/10.1158/1078-0432.CCR-10-1297
Published: 16 December 2010
View article titled, CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Open the PDF for CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy

Jenny J. Hong, Steven A. Rosenberg, Mark E. Dudley, James C. Yang, Donald E. White, John A. Butman, Richard M. Sherry
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19): 4892–4898.
https://doi.org/10.1158/1078-0432.CCR-10-1507
Published: 29 September 2010
View article titled, Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
Open the PDF for Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy in another window